Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Capponi

Showing results (541-550 of 561) with videos related to

Pageof 57
Sort By:
Hemasphere|July 10, 2026
Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trialLuca De Carolis, Monia Capponi, Alessandro Mancini, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Genome writing to dissect consequences of SVA retrotransposon disease X-Linked Dystonia ParkinsonismWeimin Zhang, Yu Zhao, Priya Prakash, et al.
Hematological Oncology|May 29, 2023
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana LinfomiMaria E Nizzoli, Martina Manni, Chiara Ghiggi, et al.
Frontiers in Immunology|January 4, 2021
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe CasesRita Carsetti, Salvatore Zaffina, Eva Piano Mortari, et al.
Hemasphere|November 17, 2025
Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R)Luca De Carolis, Monia Capponi, Andrea Bernardelli, et al.
Scientific Data|May 18, 2023
A continent-wide detailed geological map dataset of AntarcticaSimon C Cox, Belinda Smith Lyttle, Samuel Elkind, et al.
Journal of Thrombosis and Thrombolysis|March 2, 2021
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19Marco G Mennuni, Giulia Renda, Leonardo Grisafi, et al.
Physical Review. A, Atomic, Molecular, and Optical Physics|May 1, 1993
Antiproton stopping power in hydrogen below 120 keV and the Barkas effectAdamo, Agnello, Balestra, et al.
Physical Review. A, Atomic, Molecular, and Optical Physics|December 1, 1996
Experimental antiproton nuclear stopping power in H2 and D2Bertin, Bruschi, Capponi, et al.
The New England Journal of Medicine|June 14, 2011
BRAF mutations in hairy-cell leukemiaEnrico Tiacci, Vladimir Trifonov, Gianluca Schiavoni, et al.
Pageof 57

Showing results (541-550 of 561) with videos related to

Sort By:
Pageof 57
Hemasphere|July 10, 2026
Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trialLuca De Carolis, Monia Capponi, Alessandro Mancini, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Genome writing to dissect consequences of SVA retrotransposon disease X-Linked Dystonia ParkinsonismWeimin Zhang, Yu Zhao, Priya Prakash, et al.
Hematological Oncology|May 29, 2023
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana LinfomiMaria E Nizzoli, Martina Manni, Chiara Ghiggi, et al.
Frontiers in Immunology|January 4, 2021
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe CasesRita Carsetti, Salvatore Zaffina, Eva Piano Mortari, et al.
Hemasphere|November 17, 2025
Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R)Luca De Carolis, Monia Capponi, Andrea Bernardelli, et al.
Scientific Data|May 18, 2023
A continent-wide detailed geological map dataset of AntarcticaSimon C Cox, Belinda Smith Lyttle, Samuel Elkind, et al.
Journal of Thrombosis and Thrombolysis|March 2, 2021
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19Marco G Mennuni, Giulia Renda, Leonardo Grisafi, et al.
Physical Review. A, Atomic, Molecular, and Optical Physics|May 1, 1993
Antiproton stopping power in hydrogen below 120 keV and the Barkas effectAdamo, Agnello, Balestra, et al.
Physical Review. A, Atomic, Molecular, and Optical Physics|December 1, 1996
Experimental antiproton nuclear stopping power in H2 and D2Bertin, Bruschi, Capponi, et al.
The New England Journal of Medicine|June 14, 2011
BRAF mutations in hairy-cell leukemiaEnrico Tiacci, Vladimir Trifonov, Gianluca Schiavoni, et al.
Pageof 57